Clinical Trial Update: Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of dasatinib in previously treated metastatic colorectal cancer has completed; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Sprycel (dasatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-09-10